Clobazam Tablet
Product Images NDC 69238-1306

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 69238-1306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4 (Clobazam Tablets 1)

FDA Label Image

2 (Clobazam Tablets 2)

This appears to be a chart or graph displaying the percentage reduction in weekly drop seizure rate. The chart indicates that there were 121 respondents, and the three columns may represent different levels of treatment or severity (low, medium, high). However, the text "%83" is not clear and may be a misread or error.*

FDA Label Image

3 (Clobazam Tablets 3)

FDA Label Image

10 (Clobazam Tablets 4)

FDA Label Image

20 (Clobazam Tablets 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.